text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 461432-26-8 | Product Number: D6234

Dapagliflozin


Purity: >95.0%(HPLC)
Synonyms:
  • (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
  • (1S)-1,5-Anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
  • BMS 512148
Product Documents:
1G
€98.00
Contact Us ≥60 
5G
€315.00
Contact Us 1  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number D6234
Purity / Analysis Method >95.0%(HPLC)
Molecular Formula / Molecular Weight C__2__1H__2__5ClO__6 = 408.88 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (<0°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Heat Sensitive
CAS RN 461432-26-8
Reaxys Registry Number 11966426
MDL Number

MFCD13182359

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 95.0 area%
Specific rotation +15.0 to +19.0 deg(C=0.1, CHCl3)
Water max. 2.0 %
NMR confirm to structure
Properties (reference)
Melting Point 88 °C
GHS
Pictogram Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
H361 : Suspected of damaging fertility or the unborn child.
H362 : May cause harm to breast-fed children.
Precautionary Statements P263 : Avoid contact during pregnancy and while nursing.
P260 : Do not breathe dust or mist.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Related Laws:
Transport Information:
HS Number 2932990090
Application
Dapagliflozin: A Sodium-Dependent Glucose Transporter 2 (SGLT2) Inhibitor

Sodium-dependent glucose transporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for most of the reabsorption of filtered glucose from the tubular lumen.1) The inhibitors, including dapagliflozin (BMS-512148), suppress the reabsorption of filtered glucose in the proximal renal tubules.2-4) Therefore, the inhibitors can control blood glucose by excreting excess glucose in the urine. SGLT2 inhibitors also reduce sodium reabsorption and increase sodium delivery to the distal tubule. This has been reported to affect several physiological functions, including the reduction of cardiac preload and afterload.5) (The product is for research purpose only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.